Background: Several studies in animal models suggest a possible effect of the specific part of the Y-chromosome (Y NPAR ) on brain opioid, and more specifically on brain b-endorphin (BE). In humans, male prevalence is found in autistic disorder in which observation of abnormal peripheral or central BE levels are also reported. This suggests gender differences in BE associated with genetic factors and more precisely with Y NPAR .
. In addition, neonatal injection or exposure to testosterone contributes to the ''male pattern'' of the ontogenesis of m receptors in the hypothalamus and to the development of BE innervations in the brain [2] [3] [4] [5] [6] . Inversely, intracerebro-ventriculaire injection of BE decreases plasma Luteinizing Hormone concentration and consequently plasma testosterone concentration; this effect involves the m receptors and is blocked by the preliminary administration of Naloxone (an antagonist of the m receptors) [7] [8] [9] [10] . Given these previous observations and because Y NPAR is involved in plasma testosterone concentration and testicular reactivity to testosterone [11, 12] , the Y NPAR is expected to be associated with brain BE.
This hypothesis of an effect of the Y NPAR on brain BE is also supported by studies in mice models and in humans showing an inhibitory influence of central opioids acting through the m receptors (such as BE) on aggressive behavior [13] [14] [15] [16] [17] [18] [19] [20] , and an effect of the murine Y NPAR on aggression [21] [22] [23] [24] [25] . In addition, Laarakker et al.'s study [26] reporting a contribution of the Y NPAR to anxiety-related behavior in mice, strengthens the hypothesis of an effect of the Y NPAR or brain BE, given that BE is considered as a stress hormone [27] [28] [29] .
Finally, in humans, and more precisely in autistic disorder, two other arguments support our hypothesis: on one hand, the fourfold higher prevalence of autism in male compared to female [30] (autism is a pervasive developmental disorder for which family and twin studies suggest a genetic contribution [31] [32] [33] ) could indicate a contribution of the Y NPAR ; on the other hand, several studies have reported abnormal central as well as peripheral BE levels in individuals with autism [34] .
The present study was designed first to test directly the effect of Y NPAR on brain BE levels in two highly inbred strains of mice, NZB/BlNJ (N) and CBA/HGnc (H), and their consomic strains for the Y NPAR . Second, an indirect effect of the Y NPAR on brain BE level via plasma testosterone was tested by studying the genetic correlation between brain BE concentration and plasma testosterone concentration in eleven highly inbred strains of mice.
Methods

Mice and rearing conditions
Brain b-endorphin and plasma testosterone were measured in a set of inbred strains of mice and in a quartet of parental and their consomic strains for the Y NPAR . The set of inbred strains consisted in 11 inbred mouse strains A/J, XLII, BA, BALB/cBy, C57BL/ 10Bg, C57BL/6Jby, CPB-K, DBA/1Bg, DBA/2j, CBA/HGnc and NZB/BlNJ. The strains were maintained in the laboratory for six or more generations of brother-sister mating regimen. The quartet of parental and their consomic strains for the Y NPAR was developed as follows: we selected two strains of laboratory mice NZB/BlNJ (N) and CBA/HGnc (H) that were known for the different origin of their respective Y chromosomes. Furthermore, N and H were selected because the N males, who present the highest scores for aggression and the highest plasma testosterone concentration compared to the H males [1, 3, [7] [8] [9] [10] [13] [14] [15] [16] [17] [18] [19] [20] , were expected to have also lower brain BE levels as suggested by previous reports described in the introduction [13, 35] . The production of the consomics for the Y NPAR has been previously described [12, 36] 28 under these conditions. In addition, with homozygous autosomal alleles no genomic imprinting could contribute to the difference between a parental and its congenic strain. The isogenicity between each parental and its consomic strain was confirmed by the acceptance of reciprocal skin grafts and identity of mandible shape measurements [37, 38] because both are controlled by a large number of loci spread on the genome [39] . This isogenicity between each parental and the respective consomic strain was also tested by comparing 123 Mit polymorphisms (unpublished). Moreover, each parental strain and its consomic had identical genetic information for the Sts locus mapped on the Y PAR [36] . Four to six littermates were housed with their mother in a 42611618 cm plastic cage and a bedding of dust-free sawdust with food and water ad libitum, temperature 24.060.5uC and lights on at 08:00 AM. Weaning took place at 2862 days of age. Males were then placed with the same age female (usually a littermate) and were killed at 6664 days by cervical dislocation. Cervical dislocation was selected as being the more rapid technique for euthanasia. The whole brains (after removing olfactory bulbs and cerebellum) were saved for biochemical analyses and stored at 280uC. The blood was collected by intracardiac puncture in 10 ml of heparin and the plasma was kept at 225uC. The experimental protocol with the mice was conducted according to the European guidelines and was approved by the National Committee of the Scientific Research (CNRS).
Biochemical analyses
Brain tissues were homogenized in 5 volumes of 0.1 M HCl and heated for 15 min at 95uC. After centrifugation (38,0006g, 10 min, 4uC), the supernatant was adjusted to pH 7.0 with 1 M Tris base, and the resulting precipitate was spun down at 6,0006g for 10 min at 4uC. Protein concentrations were determined in the pellets by the method of Lowry et al. [40] with bovine serum albumin as the standard. Brain BE levels are expressed in picomoles per gram of fresh tissue.
The plasma testosterone was assayed according to RIA in coated tubes using a specific testosterone antibody exhibiting a reduced cross-reaction (7.5%) with other androgen steroids ( 125 I-TESTOSTERONE COATRIA, kit Biomérieux). The competitive inhibition reaction was measured between a fixed amount of 125 I-labelled testosterone and the testosterone to be determined (standards or samples) for a fixed number of binding sites on the anti-testosterone antibody. Coated tubes, containing plasma and 125 I-testosterone tracer, were incubated for 2 h at 37uC. The 125 I-testosterone bound was separated from that remaining in solution. The bound radioactivity counted for 1 min was then inversely proportional to the testosterone quantity in standards or samples. Each individual sample was assayed in duplicate and the sample again assayed when the difference between the two results was over 20%.
Statistical analyses
The effect of the Y NPAR on brain BE level and plasma testosterone concentration was studied using a two-way ANOVA, with genetic background -H versus N-and origin of the Y NPAR -H versus N-as main factors. Effect size was calculated using the h 2 statistic and expressed as a percentage of variance [41] . Comparisons between the 11 inbred mouse strains for BE or testosterone variables were performed using ANOVA. The Kolmogorov-Smirnov test indicated that BE and testosterone levels were not normally distributed; thus all ANOVAs were performed using log-transformed BE and testosterone values. Correlations between brain BE levels and plasma testosterone concentrations in the 11 inbred mouse strains (each strain is represented by the mean of five animals for biological variables) were determined by Spearman rank-order correlation analyses. According to Hegmann and Possidente [42] , these correlations between biological measures can be considered as an estimation of genetic correlations. The significance level was set at 0.05; however, the usual level of 0.05 is very conservative when the correlations are computed on mean scores and not on individual scores.
Results
Effect of the Y NPAR on brain b-endorphin levels
Brain BE levels were significantly modified by the non-Y Correlation between b-endorphin and testosterone
The data of brain BE levels and plasma testosterone concentrations (mean 6 SEM) in the 11 inbred strains are presented in Table 1 . The 11 inbred mouse strains did not differ significantly for BE or testosterone concentrations. In addition, there was no correlation between brain BE levels and plasma testosterone concentration when the analysis was conducted on the eleven different inbred strains including the same N and H males contributing to the present study (r spearman = 0.09, P.0.1).
Discussion
Our main data indicated a significant and major effect of the Y NPAR in interaction with the genetic background on brain BE levels. The controls to ensure the isogenicity of the background in each parental strain and its consomic strain rule out a possible contribution of residual autosomal alleles from the donor strain to this effect of the Y NPAR in interaction with the genetic background. None of the annotations of the genes carried by the Y NPAR allows us to consider that one of them contributes directly in the BE production [43] .
An indirect effect of the Y NPAR in interaction with the genetic background on brain BE levels via plasma testosterone is not supported by our findings. Indeed, there was no correlation in this study between brain BE levels and plasma testosterone concentrations, although this research is limited by the absence of variability of BE or testosterone concentration between the 11 inbred strains. In addition, our results on plasma testosterone measured in the parental N and H and their consomic strains confirm our previous study [12] and indicate that the strain distribution pattern differs for brain BE levels and plasma testosterone concentrations; the Y NPAR from N, which depleted BE on the H background, had no effect on testosterone. Thus, the strong decremental effect on brain BE levels resulting from the transfer of the Y NPAR from N on H, cannot be explained by variations of plasma testosterone concentrations. The effect of the Y NPAR on brain BE concentration in interaction with the genetic background reported in the present study is the first demonstration of Y-chromosome mediated control of brain opioid. The results open new perspectives to better understand sex differences observed in some disorders such as autistic disorder, where abnormal central BE levels have been reported. Finally, the findings could have important implications for research on the genetic control of BE metabolic pathways. 
